Inscripta
Latest round
- Series E
Last raised
- Mar 2021
Total raised
- $372M
Investors
- 14
About Inscripta
Inscripta, Inc. is dedicated to advancing gene editing technologies. Founded in 2015 by Andrew Garst, the company has pursued a trajectory of innovation in the biotechnology sector.79 mn.Inscripta® specializes in advanced biomanufacturing technologies, leveraging a unique approach known as Lean Bioengineering™, which combines Directed Evolution, CRISPR+, and Machine Learning. Their flagship product, GenoScaler™, is designed to identify and recombine genetic edits, creating strains with the highest commercial potential for various applications. This technology enables rapid testing of large sets of genetic solutions, significantly improving traits in biomanufactured products. Inscripta® serves a diverse client base that includes biotechnology firms, pharmaceutical companies, and agricultural enterprises looking to innovate and enhance their product offerings.Inscripta® generates revenue through direct business transactions with clients primarily in the biotechnology and agricultural sectors. The company's revenue structure is based on partnerships and collaborations, where clients engage with Inscripta® for access to their proprietary technologies, including GenoScaler™. These transactions typically involve service agreements and project-based pricing for the development and optimization of customized genetic solutions. Inscripta®'s business model focuses on delivering value through innovative solutions that enhance biomanufacturing processes, promoting efficiency and cost-effectiveness for its clients.Inscripta, Inc. The company is actively designing new products aimed at optimizing biomanufacturing processes, although specific launch dates have not been disclosed. Additionally, Inscripta® is targeting expansion into key markets in Asia and South America by the end of 2024, aiming to establish a broader presence in these emerging regions.
Who invested in Inscripta
14 investors across 7 rounds
See all investors in Inscripta
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Mar 30, 2021
Amount
$150M
Investors
Series D
Nov 27, 2019
Amount
$92M
Investors
Series C
Apr 4, 2019
Amount
$20M
Investors
Series C
Jan 4, 2019
Amount
$26M
Investors
Series C
Feb 20, 2018
Amount
$55M
Investors
Series B
Feb 16, 2017
Amount
$23M
Investors
Series A
Apr 29, 2016
Amount
$6M
Investors
Questions about Inscripta
Who invested in Inscripta?
Inscripta has 14 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inscripta raised?
Inscripta has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Inscripta last raise money?
Inscripta's most recent round on record is a Series E, in Mar 2021.
What does Inscripta do?
Inscripta is a biotechnology company.
Where is Inscripta headquartered?
Inscripta is headquartered in Pleasanton, US.
Which VCs invest in companies like Inscripta?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inscripta's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Inscripta? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.